A rabbit model was used to study the effect of allogeneic demineralized bone powder (DBP) implants on the persistence of Staphylococcus aureus osteomyelitis. Thirty-one rabbits with chronic osteomyelitis of the tibia established by day 21, were started on systemic antibiotics followed by either no additional treatment or debridement plus either DBP (with or without supplemental antibiotics) or supplemental antibiotics only. On day 21, cultures showed a mean of 2 x 104 CFU/mg of debrided osseous material. By day 70, the treatment most effective in clearing infection was found in animals treated with supplemental antibiotics only (mean of 142 -116 CFU/mg). In contrast, infection persisted at a 7-to 10-fold-higher level in animals receiving DBP with and without supplemental antibiotics; these results suggest that DBP contributed to persistence of infection. Longitudinal sera were tested again staphylococcal sonic extracts by immunoblot. Detection of numerous probe-positive bands indicated complex but remarkably similar antibody responses among infected animals. Antibodies attached directly to the cell surfaces of staphylococci as shown by immunogold and blocked the binding of organisms to HEp-2 and human fetal lung cells in a radioadherence assay. Antibodies could be absorbed out by intact organisms and were unreactive by immunoblot against antigens derived from cells pretreated with pronase, proteinase K, or lysostaphin. These results indicate that the major response was directed against staphylococcal cell surface proteins. Surprisingly, only one major band (molecular weight, -12,000) was detected when a homologous in vivo antigen preparation was studied by immunoblot. Antibody reactive against this peptide did not appear to react with staphylococci grown in vitro.
A rabbit model was used to study the effect of allogeneic demineralized bone powder (DBP) implants on the persistence of Staphylococcus aureus osteomyelitis. Thirty-one rabbits with chronic osteomyelitis of the tibia established by day 21, were started on systemic antibiotics followed by either no additional treatment or debridement plus either DBP (with or without supplemental antibiotics) or supplemental antibiotics only. On day 21, cultures showed a mean of 2 x 104 CFU/mg of debrided osseous material. By day 70, the treatment most effective in clearing infection was found in animals treated with supplemental antibiotics only (mean of 142 -116 CFU/mg). In contrast, infection persisted at a 7-to 10-fold-higher level in animals receiving DBP with and without supplemental antibiotics; these results suggest that DBP contributed to persistence of infection. Longitudinal sera were tested again staphylococcal sonic extracts by immunoblot. Detection of numerous probe-positive bands indicated complex but remarkably similar antibody responses among infected animals. Antibodies attached directly to the cell surfaces of staphylococci as shown by immunogold and blocked the binding of organisms to HEp-2 and human fetal lung cells in a radioadherence assay. Antibodies could be absorbed out by intact organisms and were unreactive by immunoblot against antigens derived from cells pretreated with pronase, proteinase K, or lysostaphin. These results indicate that the major response was directed against staphylococcal cell surface proteins. Surprisingly, only one major band (molecular weight, -12,000) was detected when a homologous in vivo antigen preparation was studied by immunoblot. Antibody reactive against this peptide did not appear to react with staphylococci grown in vitro.
One approach to the surgical repair of experimentally induced osseous defects has been the use of demineralized bone implants (19) , which act by inducing the transformation of local host mesenchymal cells to osteoblasts, leading to bone formation. Such implants have been used clinically in the successful repair of defects in a limited number of patients (19, 24, 32) . As noted in a recent review by Gristina (14) , devitalized bone implants fall into the same category as nonvital biomaterial implants, such as artificial joints and contact lenses, composed of metal or polymers. One of the main problems in the use of these implants is the potential for infection. In fact, failure of bone implants is most commonly caused by infection, and if even low-grade sepsis occurs, the bone implant must be removed (19, 24) .
Although the primary purpose for the use of bone implants in osseous defects is to initiate repair of the defect, the impact of implants on preexisting or acquired infections of the bone has never been determined. In this study, we used a modification of the model of chronic osteomyelitis originally described by Norden (25) to establish a Staphylococcus aureus osteomyelitis of the tibia in rabbits. S. aureus was selected for study because this organism continues to be the major isolate from osteomyelitis in humans, including patients with septic nonunion fractures who have been treated by conventional bone-grafting procedures and longterm systemic antibiotic therapy (13, 22 ). The infected rabbits were then subjected to various treatments, including allogeneic demineralized bone powder (DBP) implants (with and without supplemental antibiotics). Local supplemental antibiotic therapy was included because Rodeheaver et al. (28) found that antibiotic-impregnated polymethylmethacrylate cement significantly reduced the numbers of S. aureus when used to fill the medullary canals of infected rabbit femora. In our study, the various treatments were evaluated for effects on the level of bone infection that existed at the time of sacrifice as determined by quantitative colony counts. Another major purpose of this study was to characterize the humoral immune response of infected animals by identifying the major antigens that elicited antibody production over time and to compare the in vitro and in vivo antigenic profiles of the infecting organism.
MATERIALS AND METHODS Bacteria. S. aureus Ci-1, isolated from a patient with a deep-seated staphylococcal infection, was used throughout the study. The bacteriophage type, phenotypic characteristics, sensitivity to heavy metals and antibiotics, and cell surface hydrophobicity of the isolate have been reported (30 28 of the 34 animals were anesthetized as described above, and 1.8 ml of 2% lidocaine hydrochloride with epinephrine (1:100,000) was infiltrated into the infected tibia to assist with hemostasis. The wound was surgically opened, and the osseous lesions were exposed and debrided by removal of the grossly visible diseased tissue, using curettes and a bone drill. The bony defect of the tibia created by the surgical debridement involved cortical and medullary portions of the tibia. The defect was standardized by constructing an area 1.0 cm long and 0.5 cm wide, using a dental round burr, which in some animals necessitated enlarging the area exposed by debridement. On day 21, these animals were started on a 3-week course of systemic antibiotic therapy with subcutaneous injections of Keflin (cephalothin sodium; Eli Lily & Co., Indianapolis, Ind.) every two groups of animals also received DBP implants along with the Gelfoam-Keflin paste.
Blood cultures. Approximately 5 ml of whole blood was collected aseptically from the marginal ear veins on day 1 (15 min after each animal had been inoculated with staphylococci), on day 21 (15 min after the medullary cavity had been debrided and treated), and on days 48 and 70 (the time of sacrifice). The blood was allowed to clot, and the serum was removed and stored in small volumes at -20°C; the clot was macerated, transferred to a bottle containing 30 ml of ToddHewitt broth, and incubated at 37°C for 5 days; positive cultures were further subcultured onto 5% sheep blood agar and incubated for 18 h at 37°C, after which time the isolates were identified as coagulase-positive S. aureus by standard bacteriological techniques.
Bone cultures. The debrided material obtained on day 21 was collected into a sterile petri dish for quantitative culture; the debrided material was weighed, suspended in 5 ml of sterile PBS, and homogenized in a Ten Broeck tissue grinder. The homogenate was pelleted by centrifugation (10,000 x g for 15 min), the supernatant fluid was discarded, and the pellet was suspended in 0.5 ml of sterile PBS. Tenfold serial dilutions were made in PBS; 0.1 ml of each dilution was plated in triplicate, overlaid with molten agar, and incubated for 18 h at 37°C, and the total number of CFU present in each specimen was determined. Data are expressed as mean CFU of S. aureus per milligram of debrided material. A 0.1-ml volume of the undiluted specimen was also plated on blood agar for definitive identification of isolates. On day 70, anesthetized animals were sacrificed by an injection of T-61 euthanasia solution (American Hoechst Corp., Somerville, N.J.). The medullary cavity of each right tibia was debrided, and the material was processed for quantitative cultures as described above.
Immunoblot assay. Bacterial antigens used in the immunoblot assay were obtained as follows. (i) S. aureus Ci-1 was subcultured onto a 5% sheep blood agar plate and incubated at 37°C for 18 h. Two colonies were transferred to 20 57, 1989 6 x 108 CFU/ml, the tube was placed in ice, and the cells were sonicated for 90 s with a model W140D cell disruptor (Heat Systems-Ultrasonics, Inc., Plainview, N.Y.) with a setting at the microtip limit. Suspensions of broken cells were heated at 100°C for 90 s and stored at -70°C. (ii) An in vivo antigen preparation of the Ci-1 strain was made by pooling homogenated debrided material harvested from infected osseous lesions of the 26 rabbits that survived through day 70. Staphylococci were obtained by differential centrifugation (3,000 rpm, 3 min); the supernatant contained a total of 2 x 107 CFU of staphylococci, which were pelleted by centrifugation, washed, suspended in 500 RI of sample buffer, and processed as described above. The pellet containing tissue debris minus staphylococci was also processed and used as a control antigen. (iii) Clumping factor was isolated from the water-soluble phase of strain Ci-1 by affinity chromatography on fibrinogen-linked Sepharose 4B according to the procedure described by Espersen et al. (9) . A 40-pl volume of each test antigen preparation containing 50 pug of total protein was heated at 100°C for 10 min and subjected to electrophoresis (120-V constant current) on a 5% stacking and 10% resolving sodium dodecyl sulfatepolyacrylamide electrophoresis gel according to the method of Laemmli (21) . Separated polypeptides were electroeluted from the gel onto untreated nitrocellulose paper by electrophoresis at a constant current of 20 mA for not less than 48 h in buffer (14% glycine, 0.3% Tris, 20% methanol). Individual lanes were cut out, and unbound sites on each strip were quenched by soaking for 1 h in 1% bovine serum albumin in the TSGAN buffer described by Cohen and Falkow (6), which consisted of 50 mM Tris hydrochloride (pH 7.5), 0.15 M NaCl, 0.25% gelatin, 0.15% sodium azide, and 0.1% Nonidet P-40. Each strip was rinsed three times in TSGAN and overlaid with a 1:100 dilution of the appropriate rabbit serum in TSGAN for 18 h at ambient temperature. The strips were rinsed three times with TSGAN and overlaid with TSGAN containing sta4hylococcal protein A (Sigma) previously labeled with 12 I by the chloramine T method of Daugharty et al. (7) 
RESULTS
A total of 34 rabbits were inoculated intratibially, 31 with viable S. aureus (groups I through V) and three with heatkilled cells (group VI); five (16%) died after treatment was initiated but before day 48 and included three rabbits from group I and one each from groups II and V. Blood culture results indicated that 26 of 31 rabbits (85%) were culture positive for S. aureus when the blood was drawn shortly after the animals were inoculated with viable staphylococci on day 1; 8 of 31 animals (26%) were also culture positive for blood samples drawn shortly after the first debridement on day 21 . All subsequent blood cultures collected after initiation of treatment were negative except for one positive culture on day 70 from a rabbit in group V. The three rabbits in group VI that were originally inoculated with heat-killed S. aureus all survived the 70-day experiment; blood cultures from these animals were consistently negative, and none of the rabbits developed lesions.
Results of quantitative bone cultures are shown in Fig. 1 . S. aureus osteomyelitis was established in all 28 animals debrided on day 21. On day 70 (time of sacrifice), bone cultures were repeated on the 24 survivors in groups I through IV and were also done on the two remaining animals in group V to demonstrate the level of infection in animals that had received the full course of systemic antibiotics but that had received no additional treatment. These animals (group V) had a fourfold reduction in CFU of S. aureus compared with culture results obtained on day 21 . The treatment most effective in reducing infection was seen in group IV, in which the seven rabbits were debrided on day 21 and the osseous defect was packed with the Gelfoamantibiotic mixture; two of these seven animals were culture negative. In contrast, persistent staphylococcal infection was seen in groups I through III at a level that was 7-to 10- A total of 116 preimmune and immune sera were collected from 29 surviving rabbits in groups I through VI. Immunoblots were done on the sera (Fig. 2) . By day 48, a marked humoral response was evident in all animals in groups I and II, the antigen-positive profiles were essentially identical, and chronic infection persisted in these animals through day 70 (Fig. 1) . As a whole, sera from the seven animals in group III gave similar results in the immunoblot assay; these animals had persistent infection to day 70 even though they received local antibiotic therapy. In contrast, no humoral response was detected in the animals from group IV (Fig. 2,  lanes 10 through 12) , which were treated with local antibiotics but did not receive DBP; the two spots between lanes 10 and 11 are artifacts. Sera from two of three animals that survived to day 70 in group V (systemic antibiotics only) had antibodies detectable by day 48 that persisted to day 70, as did their chronic infections (Fig. 2, lanes 13 through 15) ; however, the response against the higher-molecular-weight (>52,000) peptide bands was much weaker than in groups I through III. Immunoblot results were negative with sera obtained from the three animals in Group VI that were inoculated with heat-killed staphylococci (data not shown). All mune (day 70) serum was tested in the immunoblot assay for antibodies against peptides derived from the homologous infecting strain of Ci-1 grown either in vitro or harvested from pooled debrided material taken from infected tibias (in vivo) and a heterologous strain of S. epidermidis (Fig. 3) . A typical complex antigenic pattern was obtained with the in vitro sonic extract (lane 1) which differed significantly from the patterns of the other two antigen preparations. One dominant probe-positive band of low molecular weight (-12,000) was seen with the in vivo sonic extract (lane 2); this band did not comigrate with peptides from the in vitro antigen preparation. The control sonic extract of tissue debri minus staphylococci was negative (data not shown). Specificity of the immune response for S. aureus was supported by the antigenic profile obtained with the S. epidermidis sonic extract, in which two major high-molecular-weight bands were probe positive (lane 3). Only the in vitro sonic extract had probe-positive bands with molecular weights consonant with purified clumping factor and protein A.
An experiment using an immunoelectron microscopy technique was done to determine whether antibodies present in hyperimmune serum (day 70) were directed against staphylococcal surface antigens. As might be expected, direct binding of antibodies was detectable when Ci-1 was reacted with hyperimmune serum. To eliminate the possibility that these antibodies were reacting nonspecifically with protein A on the surface of the staphylococci, Ci-1 was pretreated with preimmune rabbit serum to block protein A-binding sites and then incubated in hyperimmune serum (Fig. 4A) . The antibodies, which appeared to be uniformly dispersed, were found to bind to surface antigens. Results were negative with organisms incubated in buffer only or in preimmune rabbit serum only (Fig. 4B) .
To resolve the question of whether the antibodies reacting in the immunoblot assays were also detecting antigenic peptides derived from the surface of Ci-1, an absorption experiment was done. As expected, absorption of hyperimmune serum with untreated Ci-1 removed all antibody activity. To block nonspecific binding of antibodies to protein A, Ci-1 was pretreated with preimmune rabbit serum (untreated or pretreated to remove any naturally occurring antistaphylococcal antibodies) and then used to absorb the hyperimmune serum. This procedure was successful in removing antibody activity against all of the reactive peptides in the in vitro sonic extract, the minor reactive peptides in the in vivo sonic extract, and all reactive peptides in the S. epidermidis sonic extract. These results suggest that all of the in vitro Ci-1 probe-positive bands detectable by immunoblot were surface derived and that the minor in vivo and S. epidermidis peptide bands were antigenically cross-reactive. In contrast, antibody activity against the major reactive peptide in the in vivo sonic extract was unaffected by absorption.
A radioassay was done to determine whether antibodies directed against Ci-1 surface antigens were capable of blocking the adherence of Ci-1 to mammalian cell monolayers (Fig. 5) 
DISCUSSION
Results from the in vivo aspect of this study clearly indicate that DBP, potentially useful in initiating repair of an osseous defect, may actually cause exacerbation of a preexisting infection in animals with chronic staphylococcal osteomyelitis. Infection persisted in rabbits that had received a prolonged course of systemic antibiotics and whose debrided lesions were exposed to DBP with (group III) or without (groups I and II) supplemental local antibiotic therapy. In contrast, animals whose osseous defects were treated with the same dose of local antibiotic in the absence of DBP (group IV) demonstrated a dramatic decrease in infection; the mean CFU was 10-fold less than values obtained from animals in groups I through III and 50-fold less than those obtained from untreated control animals (group V). These observations may be explained in part by the fact that bacteria in infected bone form thick, tenacious biofilms (15, 16, 23, 33) that probably hinder clearance of the organisms by mechanical debridement or systemic antibiotics. Consequently, the introduction of an implant into such a contaminated lesion might provide the bacteria with a susceptible substrate for adherence and colonization. It is also possible that the use of smaller particles of bone powder, which are more osteoinductive than larger particles (12) , compounded the problem by providing more surface area available for staphylococcal adherence.
In the longitudinal serological aspect of this study, results indicated that a heightened humoral immune response was primarily an indicator of persistent infection (Fig. 2) . The immune response was weak to nil in animals whose infections were successfully cleared (group IV) or in animals that were sham challenged with nonviable organisms (group VI).
Immunoblots were used to follow the immune responses in the remainder of animals with infections that persisted through day 70 (groups I, II, III, and V); antibody profiles were complex but remarkably uniform. Animals differed primarily in the timing of appearance of antibodies against particular peptide bands or in the intensity of reactivity, which increased over time. The immune response in experimentally infected rabbits and patients with staphylococcal osteomyelitis has also been reported by Espersen and Hedstrom (10, 11) 
ANTIBODY RESPONSE IN OSTEOMYELITIS AFTER IMPLANTS
compared with the profile of S. aureus grown in vivo. All of the in vitro major reactive bands were either lost or dramatically decreased in the in vivo antigen preparation, which demonstrated only one major low-molecular-weight band (Fig. 3) . One possible explanation of these results is the potential for phenotypic variation when cells are grown under different conditions (1, 4) and particularly in infected tissue, where antigenic composition may differ greatly from that of cells grown under the usual laboratory conditions (3, 35, 36) in the absence of adverse conditions (20, 26) . It is also possible that cells growing or present in vivo over the 70-day period of infection may be subject to host factors such as enzymatic activity or to innate factors of the bacteria such as aging or the action of autolysins on cells that are no longer actively growing. Likely, a combination of these possibilities exists. One has to be concerned that the majority of work done in dissecting the antibody response to potential pathogens uses laboratory-grown, if not -adapted, strains for testing, and the results in any such study may not reflect what actually occurs in the infected host.
We were able to demonstrate that at least some antibodies from infected animals were directed against surface antigens of in vitro-grown cells by using an immunogold procedure (Fig. 4) ; antibodies appeared to be evenly dispersed over the surfaces of the cells. Furthermore, absorbing hyperimmune sera with intact (in vitro-grown) cells successfully removed all antibody against the in vitro-grown cells used as antigens in the immunoblot. These results strongly suggest that the immune response was directed primarily, if not exclusively, against cell surface antigens. Absorption of the sera also removed antibodies against the minor probe-positive bands in the in vivo antigen preparation. However, activity against the major in vivo band was not affected by absorption, which suggests that the antigen was not present or, if present, either was not present on the surface or was present but masked and inaccessible to the antibodies. Unfortunately, we were unable to pursue additional study of the in vivo antigens because of the limited availability of material. The absorption experiment also demonstrated that the two major probe-positive bands seen with S. epidermidis (Fig. 3) were cross-reactive with the test strain of S. aureus. Whether these antigenic peptides represent a type of common staphylococcal antigen(s) is unknown; clearly, most of the bands detected in the immunoblot of S. aureus peptides were absent in S. epidermidis.
We had noticed that the immunoblot profiles obtained with Ci-1 were similar to autoradiographs of surface-labeled proteins of the same strain (31); consequently, we were interested in determining whether the antibody response was directed against these surface proteins. Pretreatment of intact cells with protease, shown previously to release 73% of the surface-labeled proteins (31), or with proteinase K, a highly active serine protease (8) , or digestion with lysostaphin, an endopeptidase with specificity for glycylglycine peptide bridges in S. aureus cell walls (17) , was each effective in removing all of the probe-positive peptides. These results suggest that the immune response in infected animals was directed against surface proteins of S. aureus. In contrast, periodate treatment of intact cells had no effect on immunoblot profiles, which indicated that the probepositive antigens were probably not carbohydrates or amino acids susceptible to oxidation (5, 34) .
One parameter of biologic function was determined in an experiment designed simply to test whether hyperimmune rabbit antibody had the capacity to block binding of labeled S. aureus to mammalian cell monolayers in vitro. The test strain was adherence positive with HEp-2, HFL, and MDCK cells (Fig. 5) 
